Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors

Details for Australian Patent Application No. 2004215407 (hide)

International Classifications

Event Publications

8 September 2005 PCT application entered the National Phase

PCT publication WO2004/076410 Priority application(s): WO2004/076410

10 November 2005 Amendment Made

The nature of the amendment is: Amend the priority details from 607448,863 24 Feb 2003 US to 60/448,863 24 Feb 2003 US

10 November 2005 Change of Name(s) of Applicant(s), Section 104

Pharmacia & Upjohn Company The name of the applicant has been changed to Pharmacia & Upjohn Company LLC 2005

12 February 2009 Application Accepted

Published as AU-B-2004215407

12 March 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 25 Feb 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

9 July 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 25 Feb 2009

9 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.